相关实验视频
Updated: Jun 29, 2026

08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
13.2K
假设:营养脱载和子宫外脂肪减少可以逆转胰岛素抵抗并改善2型糖尿病心血管结果-A叙事评论
1Department of Internal Medicine, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
International journal of molecular sciences
|March 14, 2026
概括
像减肥手术,GLP-1受体激动剂和SGLT2抑制剂等治疗方法通过减少葡萄糖和脂肪过载,逆转胰岛素抵抗来改善2型糖尿病的心血管结果.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 心血管医学 心血管医学
背景情况:
- 2型糖尿病中的胰岛素抵抗与心血管疾病有关.
- 关键因素包括营养过重,高胰岛素血症和不活动.
- 抗胰岛素可能会在肥胖的环境中保护人免受代谢压力.
研究的目的:
- 审查减肥手术,GLP-1受体激动剂和SGLT2抑制剂在治疗2型糖尿病和心血管疾病中的作用.
- 假设这些治疗观察到的心血管益处背后的机制.
主要方法:
- 审查最近的心血管结局试验.
- 对胰岛素耐药性和代谢防御现有假设的分析.
- 综合证据,将治疗与改善的代谢参数和心血管结果联系起来.
主要成果:
- GLP-1受体激活剂和SGLT2抑制剂在2型糖尿病中显示出显著的心血管益处.
- 腹腔外科手术在心血管结果方面提供了更大的改善.
- 假设这些治疗方法可以降低葡萄糖,减少营养负载,并使能量平衡正常化.
结论:
- 腹腔外科手术,GLP-1受体激动剂和SGLT2抑制剂可降低2型糖尿病中心血管疾病的风险.
- 这些干预措施使全身能量平衡正常化,并减少子宫外脂肪.
- 这有助于逆转胰岛素抵抗,改善心血管健康.
相关概念视频
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

